Guardant Health, Inc. (GH) Competitors & Peers
The 5 largest companies in the same industry as Guardant Health, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| TMO | Peer | $694.76 | P/E 36.6RSI 55Cap 258.2 B |
| DHR | Peer | $230.25 | P/E 38.1RSI 54Cap 161.9 B |
| IDXX | Peer | $676.04 | P/E 45.6RSI 71Cap 53.3 B |
| NTRA | Peer | $310.67 | RSI 29Cap 44.5 B |
| A | Peer | $174.76 | P/E 34.5RSI 53Cap 49.4 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- EXASCompetitor
Cologuard + Guardant SHIELD compete in CRC screening.
Model-inferred, unverified — treat as a lead, not evidence - GRALCompetitor
Competes in liquid biopsy oncology screening and multi-cancer detection bids.
Model-inferred, unverified — treat as a lead, not evidence - ONCCompetitor
Both compete in precision diagnostics and biomarker-guided therapies.
Model-inferred, unverified — treat as a lead, not evidence